ESLA

Xu Jiandong

Known title: Chief Financial OfficerCIK: 0001920399

Xu Jiandong's purchase track record

How the stock did after each of Xu Jiandong's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
3
of 3 since September 11, 2025
Stock higher 6 months later
67%
3 months: 100%
Median 6-month return
+20.2%
3 months: +31.9%
Beat the S&P 500
67%
median +18.9% vs. index
PurchaseStockAmount3 months6 months
10/7/2025ESLA$1K+8.7%+36.5%
9/22/2025ESLA$1K+31.9%-12.1%
9/11/2025ESLA$104+76.9%+20.2%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 9, 2026

ESLA Among 12 Health Care Stocks Moving in Friday Pre‑Market. ESLA was one of 12 health‑care shares that saw movement in Friday’s pre‑market session. The stock traded with a volume spike and an RSI of 21.5, indicating a potential shift in interest. It remains near its 17‑touch support level of $0.74. The move comes as the broader health‑care sector shows early activity ahead of the trading day.

this person other insiders at ESLA

Transaction History

ESLA▲ Buy$82K
ESLA▲ Buy$1K
ESLA▲ Buy$1K
ESLA▲ Buy$104

We use analytics to understand how market-wall is used. No personal data is sold.